9 new incubator projects approved

The Office of the Chief Scientist has approved nine new incubator projects at an investment of NIS 15.5 million, the Ministry of Industry, Trade and Labor said Sunday.

By AVI KRAWITZ
August 14, 2006 08:32

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The Office of the Chief Scientist has approved nine new incubator projects at an investment of NIS 15.5 million, the Ministry of Industry, Trade and Labor said Sunday. Five of the approved companies are active in the medical devices sector, three in software and one in the biotechnology field. Rina Pridor, director the technological incubator program, reported that in the first six months of the year, 94 incubator companies and graduates of the program raised over $115m., including 51 that raised over $40m. in first round financing.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS